申请人:——
公开号:US20040138286A1
公开(公告)日:2004-07-15
A compound represented by the formula (1):
1
wherein R
1
—X— indicates that 1 to 4 R
1
—X— groups are present which may be the same or different,
the ring A is a saturated or unsaturated 5-membered heterocyclic ring,
X is a single bond, a group represented by the formula: —N(R
3
)—, —O— or —S—, or the like.
R
1
is a hydrogen atom, a halogen atom, a nitro group, a carboxyl group, a substituted or unsubstituted alkyl group, or the like,
R
2
is a hydrogen atom, a halogen atom, a nitro group, a carboxyl group, a substituted or unsubstituted alkyl group, or the like, and
R
3
is a hydrogen atom, a substituted or unsubstituted alkyl group, or the like;
a prodrug of said compound, or a pharmaceutically acceptable salt of said compound or prodrug is a useful compound as a therapeutic agent for diseases for which Rho kinase is responsible.
化合物的化学式为(1):1,其中R1—X—表示存在1到4个R1—X—基团,可以相同也可以不同,环A是饱和或不饱和的5元杂环,X是单键,一个由式子表示的基团:—N(R3)—,—O—或—S—等。R1是氢原子,卤素原子,硝基,羧基,取代或未取代的烷基或类似物,R2是氢原子,卤素原子,硝基,羧基,取代或未取代的烷基或类似物,R3是氢原子,取代或未取代的烷基或类似物;该化合物的前药或药物可接受的盐是治疗Rho激酶相关疾病的有用化合物。